牛牛AI助理已提取核心訊息
Vertex Pharmaceuticals Inc. officer, Sanna Bastiano, is set to sell 4,239 shares of common stock on 02/26/2024, with an aggregate market value of approximately $1,804,542. The shares to be sold were recently acquired on 02/24/2024, with 2,120 shares obtained through restricted stock vesting and 2,119 shares through performance shares, both as part of compensation from the issuer. This planned sale follows a three-month period where a total of 10,149 shares were sold by the officer, generating gross proceeds of around $4,266,460.
Vertex Pharmaceuticals Inc. officer, Sanna Bastiano, is set to sell 4,239 shares of common stock on 02/26/2024, with an aggregate market value of approximately $1,804,542. The shares to be sold were recently acquired on 02/24/2024, with 2,120 shares obtained through restricted stock vesting and 2,119 shares through performance shares, both as part of compensation from the issuer. This planned sale follows a three-month period where a total of 10,149 shares were sold by the officer, generating gross proceeds of around $4,266,460.
Vertex Pharmicals Inc.高管桑納·巴斯蒂亞諾定於2024年2月26日出售4,239股普通股，總市值約爲1,804,542美元。擬出售的股票最近於2024年2月24日被收購，其中2,120股通過限制性股票歸屬獲得，2,119股通過績效股票獲得，均爲發行人薪酬的一部分。此次計劃出售是在三個月之後進行的，該官員共出售了10,149股股票，總收益約爲4,266,460美元。
Vertex Pharmicals Inc.高管桑納·巴斯蒂亞諾定於2024年2月26日出售4,239股普通股，總市值約爲1,804,542美元。擬出售的股票最近於2024年2月24日被收購，其中2,120股通過限制性股票歸屬獲得，2,119股通過績效股票獲得，均爲發行人薪酬的一部分。此次計劃出售是在三個月之後進行的，該官員共出售了10,149股股票，總收益約爲4,266,460美元。
有用
沒用